Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.62 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 8/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.51 |
| ▸ | ACP3 | P15309 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5541823 | 0.87 | IDO1 (0.46) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL2093850 | 0.83 | TAAR1 (0.56) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL145681 | 0.82 | IDO1 (0.57) | IDO1 | |
| SCHEMBL11394076 | 0.81 | MAOB (0.39) | IDO1MAOBMAOA | |
| SCHEMBL2095502 | 0.81 | TAAR1 (0.53) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL2096391 | 0.80 | TAAR1 (0.51) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL27708411 | 0.80 | IDO1 (0.72) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL5540256 | 0.79 | HDAC1 (0.50) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL28267284 | 0.78 | IDO1 (0.70) | IDO1PRKCAPRKCDMAPTPOLB | |
| SCHEMBL39835 | 0.78 | TAAR1 (0.56) | IDO1MAPTPOLBMAOBACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103270435-B | Photosensitive transparent composition, color filter and method for producing the same, and solid-state imaging device | 富士胶片株式会社 | 2017-10-24 | — | — | CN | disclosed |
| CN-103339537-B | Light-shielding composition, method for producing same, solder resist, and method for forming pattern | FUJIFILM CORP. (JP) | 2016-02-03 | — | — | CN | disclosed |
| CN-102893215-B | Polymerizable composition | FUJIFILM CORP. (JP) | 2015-10-21 | — | — | CN | disclosed |
| CN-103339537-A | Light-shielding composition, method for producing light-shielding composition, solder resist, method for forming pattern, and solid-state imaging element | FUJI PHOTO FILM CO LTD | 2013-10-02 | — | — | CN | disclosed |
| CN-103270435-A | Photosensitive transparent composition for color filter of solid-state imaging element, method for producing color filter of solid-state imaging element using same, color filter of solid-state imaging element, and solid-state imaging element | FUJI PHOTO FILM CO LTD | 2013-08-28 | — | — | CN | disclosed |
| US-8497283-B2 | Autotaxin inhibitors | MERCK PATENT GMBH (DE) | 2013-07-30 | — | — | US | disclosed |
| CN-103038706-A | Polymerizable composition | FUJIFILM CORP | 2013-04-10 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-20130023556-A1 | AUTOTAXIN INHIBITORS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2013-01-24 | — | — | US | disclosed |
| CN-102893215-A | Polymerizable composition | FUJIFILM CORP | 2013-01-23 | — | — | CN | disclosed |
| EP-1043310-B1 | BIPHENYLAMIDINE DERIVATIVES | TEIJIN LTD (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-6706745-B1 | THERAPY FOR ANTICOAGULATION PLAYS AN IMPORTANT PART IN THE MEDICAL TREATMENT AND PROPHYLAXIS OF THROMBOEMBOLISMS | TEIJIN LIMITED (JP) | 2004-03-16 | — | — | US | disclosed |
| US-6676968-B1 | AROMATIC AMIDINE DERIVATIVES COATED WITH PH DEPENDENT SOLUBLE ENTERIC POLYMER; IMPROVING ABSORPTION THROUGH DIGESTIVE TRACTS BY REDUCING CONTACT OF BILE OR PANCREATIC JUICE | TEIJIN LIMITED (JP) | 2004-01-13 | — | — | US | disclosed |
| US-20030203935-A1 | Cyanobiphenyl derivatives | TEIJIN LIMITED | 2003-10-30 | — | — | US | disclosed |
| US-6538137-B1 | Blood-coagulation factor X inhibitors | TEIJIN LIMITED (JP) | 2003-03-25 | — | — | US | disclosed |
| US-6348478-B1 | BLOOD COAGULATION FACTORS AND ANTICOAGULANTS | TEIJIN LIMITED (JP) | 2002-02-19 | — | — | US | disclosed |
| EP-1179344-A1 | RELEASE-REGULATING PREPARATIONS | TEIJIN LIMITED (JP) | 2002-02-13 | — | — | EP | disclosed |
| EP-1179527-A1 | CYANOBIPHENYL DERIVATIVES | TEIJIN LIMITED (JP) | 2002-02-13 | — | — | EP | disclosed |
| EP-1043311-A1 | BIPHENYLAMIDINE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-10-11 | — | — | EP | disclosed |
| EP-1043310-A1 | BIPHENYLAMIDINE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023556-A1 | AUTOTAXIN INHIBITORS | ENPP2, PLA2G12A, LPCAT1 | IDO1 813/4885PRKCA 2052/4885PRKCD 3070/4885 |
| US-20030203935-A1 | Cyanobiphenyl derivatives | F9, F12, F11 | IDO1 1853/4885PRKCA 3767/4885PRKCD 3815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.